SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (20253)4/2/1999 6:07:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
AT,

Moral of the story is that earnings fundamentals eventually catch up to the hype and momentum. The same thing can be said concerning ALL the internet stocks especially the leaders such as Yahoo or AOL that do indeed have some earnings but are EXTREMELY over valuated.



To: AlienTech who wrote (20253)4/7/1999 12:50:00 AM
From: blankmind  Respond to of 23519
 
AT - Vivus is definitely a value play under $15. And at $4, it's a joke.

- the others you mentioned are a joke - except for MSFT - which I own - and has a p/e of like 70 or 80. That's actually one of the lowest of the group.

ps - are we sill waiting for VLAD's Spain approval to come thru?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News